Literature DB >> 16632868

Reciprocal regulation of cyclooxygenase-2 and 15-hydroxyprostaglandin dehydrogenase expression in A549 human lung adenocarcinoma cells.

Min Tong1, Yunfei Ding, Hsin-Hsiung Tai.   

Abstract

Human lung adenocarcinoma cells, A549, possess the capacity of expressing both cyclooxygenase-2 (COX-2) and NAD+-linked 15-hydroxyprostaglandin dehydrogenase (15-PGDH). Resting cells express little COX-2 but significant levels of 15-PGDH. Interleukin (IL) 1beta, tumor necrosis factor-alpha (TNF-alpha) or phorbol ester [phorbol 12-myristate 13-acetate (PMA)] induced the expression of COX-2, as revealed by western blot analysis. Combination of PMA and IL-1beta or TNF-alpha induced synergistically the expression of COX-2. Interestingly, cytokines and cytokine plus PMA-induced expression of COX-2 were accompanied by a downregulation of 15-PGDH. This was evident from both the western blot analysis and activity assay of 15-PGDH. It appears that the higher the expression of COX-2 was induced, the lower the expression of 15-PGDH was found. This was further supported by the observation that overexpression of COX-2 but not COX-1 by adenovirus-mediated approach led to a decrease in 15-PGDH expression, indicating the specificity of COX-2. Furthermore, downregulation of the IL-1beta-induced expression of COX-2 by silencing RNA (siRNA) approach resulted in an increase in the expression of 15-PGDH by COX-2-siRNA but not by COX-1-siRNA, indicating that it was indeed the expression of COX-2 attenuating the expression of 15-PGDH. The IL-1beta-induced reduction of the expression of 15-PGDH was shown not to be mediated by COX-2-derived products since the presence of COX-2 inhibitors did not block the attenuation of the expression of 15-PGDH. Exogenous PGE2 also did not induce the reduction of the expression of 15-PGDH. However, overexpression of 15-PGDH by transfection with recombinant plasmid encoding 15-PGDH or adenovirus-mediated approach attenuated IL-1beta-induced expression of COX-2. On the contrary, downregulation of 15-PGDH expression by 15-PGDH-siRNA or 15-PGDH-antisense approach resulted in an increase in IL-1beta-induced expression of COX-2 but not that of COX-1. In fact, it was further observed that A549 clones expressing different degrees of 15-PGDH showed also different levels of COX-2 expression after IL-1beta induction. The levels of IL-1beta-induced COX-2 expression appeared to correlate inversely with those of 15-PGDH expression in the cells. These results support the contention that COX-2 and 15-PGDH are regulated reciprocally in A549 cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16632868     DOI: 10.1093/carcin/bgl053

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  20 in total

1.  Collagen I promotes epithelial-to-mesenchymal transition in lung cancer cells via transforming growth factor-beta signaling.

Authors:  Yasushi Shintani; Masato Maeda; Nina Chaika; Keith R Johnson; Margaret J Wheelock
Journal:  Am J Respir Cell Mol Biol       Date:  2007-08-02       Impact factor: 6.914

2.  Spilanthol Inhibits COX-2 and ICAM-1 Expression via Suppression of NF-κB and MAPK Signaling in Interleukin-1β-Stimulated Human Lung Epithelial Cells.

Authors:  Wen-Chung Huang; Ling-Yu Wu; Sindy Hu; Shu-Ju Wu
Journal:  Inflammation       Date:  2018-10       Impact factor: 4.092

Review 3.  Multiple drug resistance-associated protein 4 (MRP4), prostaglandin transporter (PGT), and 15-hydroxyprostaglandin dehydrogenase (15-PGDH) as determinants of PGE2 levels in cancer.

Authors:  Tyler J Kochel; Amy M Fulton
Journal:  Prostaglandins Other Lipid Mediat       Date:  2014-11-27       Impact factor: 3.072

4.  15-PGDH is reduced and induces apoptosis and cell cycle arrest in gastric carcinoma.

Authors:  Li-Hong Lou; Da-Dao Jing; Yue-Xing Lai; Ying-Ying Lu; Ji-Kun Li; Kai Wu
Journal:  World J Gastroenterol       Date:  2012-03-14       Impact factor: 5.742

Review 5.  15-hydroxyprostaglandin dehydrogenase (15-PGDH) and lung cancer.

Authors:  Hsin-Hsiung Tai; Min Tong; Yunfei Ding
Journal:  Prostaglandins Other Lipid Mediat       Date:  2007-01-17       Impact factor: 3.072

6.  Involvement of PGE2 and PGDH but not COX-2 in thrombin-induced cortical neuron apoptosis.

Authors:  Lakshmi Thirumangalakudi; Haripriya Vittal Rao; Paula Grammas
Journal:  Neurosci Lett       Date:  2009-01-21       Impact factor: 3.046

7.  15-hydroxyprostaglandin dehydrogenase-derived 15-keto-prostaglandin E2 inhibits cholangiocarcinoma cell growth through interaction with peroxisome proliferator-activated receptor-γ, SMAD2/3, and TAP63 proteins.

Authors:  Dongdong Lu; Chang Han; Tong Wu
Journal:  J Biol Chem       Date:  2013-05-16       Impact factor: 5.157

8.  Loss of 15-hydroxyprostaglandin dehydrogenase increases prostaglandin E2 in pancreatic tumors.

Authors:  Hung Pham; Monica Chen; Aihua Li; Jonathan King; Eliane Angst; David W Dawson; Jenny Park; Howard A Reber; O Joe Hines; Guido Eibl
Journal:  Pancreas       Date:  2010-04       Impact factor: 3.327

Review 9.  Persisting eicosanoid pathways in rheumatic diseases.

Authors:  Marina Korotkova; Per-Johan Jakobsson
Journal:  Nat Rev Rheumatol       Date:  2014-02-11       Impact factor: 20.543

10.  Activation of thromboxane receptor alpha induces expression of cyclooxygenase-2 through multiple signaling pathways in A549 human lung adenocarcinoma cells.

Authors:  Jingyan Wei; Weili Yan; Xiuling Li; Wen-Chang Chang; Hsin-Hsiung Tai
Journal:  Biochem Pharmacol       Date:  2007-06-14       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.